2504, 15977, and 14760, novel protein kinase family members and uses therefor
AssigneeMillennium Pharmaceuticals, Inc.
InventorsRosana Kapeller-Libermann, Rachel A. Meyers, Rory A. J. Curtis
Life of this patent
Estimating the term…
Loading patent…
AssigneeMillennium Pharmaceuticals, Inc.
InventorsRosana Kapeller-Libermann, Rachel A. Meyers, Rory A. J. Curtis
Estimating the term…
The invention provides isolated nucleic acids molecules, designated 2504, 15977, or 14760 nucleic acid molecules, which encode novel protein kinase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 2504, 15977, or 14760 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 2504, 15977, or 14760 gene has been introduced or disrupted. The invention still further provides isolated 2504, 15977, or 14760 proteins, fusion proteins, antigenic peptides and anti-2504, 15977, or 14760 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
A method for identifying a compound which binds to a polypeptide comprising the amino acid sequence of SEQ ID NO:5, comprising the steps of:
A method for identifying a compound which modulates the activity of a polypeptide comprising the amino acid sequence of SEQ ID NO:5, comprising:
A method for identifying an agent which modulates the activity or expression of a polypeptide comprising the amino acid sequence of SEQ ID NO:5 or a nucleic acid sequence encoding the amino acid sequence of SEQ ID NO:5, comprising contacting the polypeptide or the nucleic acid with a test agent;
Dependencies are inferred from the claim text.